X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4692) 4692
Magazine Article (24) 24
Newsletter (8) 8
Newspaper Article (6) 6
Publication (4) 4
Book Chapter (1) 1
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4067) 4067
hydrochlorothiazide - therapeutic use (3189) 3189
hypertension - drug therapy (3078) 3078
male (2932) 2932
female (2601) 2601
middle aged (2506) 2506
adult (1748) 1748
aged (1741) 1741
antihypertensive agents - therapeutic use (1551) 1551
hydrochlorothiazide (1550) 1550
blood pressure - drug effects (1545) 1545
drug therapy, combination (1409) 1409
hypertension (1288) 1288
double-blind method (900) 900
hypertension - physiopathology (836) 836
hydrochlorothiazide - administration & dosage (795) 795
pharmacology & pharmacy (785) 785
hydrochlorothiazide - adverse effects (762) 762
diuretics (760) 760
diuretics - therapeutic use (693) 693
treatment outcome (612) 612
peripheral vascular disease (584) 584
drug combinations (568) 568
clinical trials as topic (562) 562
antihypertensive agents - adverse effects (500) 500
blood pressure (483) 483
blood-pressure (482) 482
antihypertensive agents - administration & dosage (441) 441
hydrochlorothiazide - pharmacology (436) 436
time factors (430) 430
angiotensin-converting enzyme inhibitors - therapeutic use (380) 380
medicine, general & internal (376) 376
tetrazoles - therapeutic use (370) 370
hypertension - complications (364) 364
hypertension - blood (337) 337
sodium chloride symporter inhibitors - therapeutic use (336) 336
drug therapy (328) 328
cardiac & cardiovascular systems (322) 322
adolescent (309) 309
animals (308) 308
heart rate - drug effects (306) 306
potassium - blood (303) 303
dose-response relationship, drug (281) 281
amlodipine (277) 277
antihypertensive agents - pharmacology (275) 275
prospective studies (275) 275
calcium channel blockers - therapeutic use (271) 271
therapy (271) 271
amiloride - therapeutic use (259) 259
random allocation (254) 254
valsartan (254) 254
aged, 80 and over (244) 244
captopril - therapeutic use (244) 244
amlodipine - therapeutic use (242) 242
angiotensin ii type 1 receptor blockers - therapeutic use (237) 237
risk factors (236) 236
double-blind (234) 234
rats (227) 227
follow-up studies (223) 223
enalapril - therapeutic use (222) 222
risk (216) 216
renin - blood (203) 203
combination therapy (200) 200
efficacy (200) 200
losartan (195) 195
medicine & public health (188) 188
tetrazoles - adverse effects (186) 186
diuretics - adverse effects (185) 185
mortality (185) 185
losartan - therapeutic use (182) 182
benzimidazoles - therapeutic use (177) 177
prevention (175) 175
internal medicine (172) 172
propranolol - therapeutic use (171) 171
diuretics - administration & dosage (169) 169
adrenergic beta-antagonists - therapeutic use (168) 168
research (166) 166
tetrazoles - administration & dosage (164) 164
antihypertensive drugs (163) 163
dosage and administration (163) 163
management (161) 161
valine - analogs & derivatives (160) 160
furosemide - therapeutic use (159) 159
atenolol - therapeutic use (157) 157
triamterene - therapeutic use (153) 153
urology & nephrology (151) 151
reserpine - therapeutic use (149) 149
combination (148) 148
methyldopa - therapeutic use (147) 147
antihypertensive therapy (146) 146
enalapril (143) 143
uric acid - blood (143) 143
analysis (142) 142
hydralazine - therapeutic use (140) 140
pharmacology/toxicology (140) 140
randomized controlled trials as topic (140) 140
spironolactone - therapeutic use (139) 139
chlorthalidone - therapeutic use (138) 138
imidazoles - therapeutic use (138) 138
health aspects (134) 134
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4064) 4064
German (203) 203
Russian (154) 154
Italian (103) 103
French (72) 72
Spanish (55) 55
Portuguese (37) 37
Chinese (23) 23
Polish (23) 23
Japanese (22) 22
Czech (13) 13
Romanian (7) 7
Norwegian (6) 6
Croatian (4) 4
Hungarian (4) 4
Danish (3) 3
Dutch (3) 3
Hebrew (3) 3
Swedish (3) 3
Ukrainian (2) 2
Bulgarian (1) 1
Finnish (1) 1
Lithuanian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Yusuf, S and Haridas, KK and Iyengar, SS and Jaison, TM and Joshi, P and Kerkar, P and Naik, S and Prabhakaran, D and Thanikachalam, S and Thomas, N and Parwani, J and Maseeh, A and Srinivasulu, B and Srinivas, J and Rangadham, K and Rayadurgee, NM and Balaji, Y and Bhavishya, Y and Parikh, K and Chag, M and Shah, U and Joseph, JJJ and Nesaraj, KJ and Malarvizhi, V and Patil, CB and Bantwal, G and Nagesh, H and Santosh, MI and Dwivedi, S and Ramesh, SS and Suresh, S and Ayyar, V and Rana, P and Tumari, DP and Agarwal, NB and Deshpande, N and Bhagchandani, R and Bhagchandani, S and Gupta, BK and Agarwal, DK and Panwar, RB and Bindu, AV and Alexander, KG and Pradeep, R and Nambiar, A and Das, CK and Ramu, M and Nayar, P and Poongothai, S and Mohan, V and Chidambaram, N and Diwan, R and Umarani, R and Bhuvaneswaran, JS and Mehta, A and Mittal, A and Sahwnay, JPS and Sidhu, G and Mehta, R and Singh, R and Bhambari, S and Rain, AR and Sastry, BKS and Rao, D and Karmalkar, M and Shah, PK and Govindaiah, P and Dharmi, S and Joshi, S and Gulla, SP and Rao, SP and Bharani, A and Patel, A and Mishra, BS and Chandwani, P and Gupta, R and Sreenivas, N and Reddy, SVR and Reddy, TVK and Kumar, V and Roy, DG and Paul, SK and Puri, A and Fisher, L and Sinha, N and Saxena, P and Kumar, S and Puri, VK and Modi, A and Thacker, HP and Mehta, K and Mehta, P and Srinivas, A and Guruprasad, HP and Bawangade, A and Khan, A and Jain, AS and Sane, D and Deshpande, M and Singh, H and ... and The Indian Polycap Study (TIPS) and Indian Polycap Study (TIPS)
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9672, pp. 1341 - 1351
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 359, Issue 23, pp. 2417 - 2428
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 02/2007, Volume 49, Issue 2, pp. 276 - 284
Thiazide diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers all cause reactive rises in plasma renin activity. We... 
Hypertension | Aliskiren | Renin inhibitor | Renin-angiotensin-aldosterone system | Combination therapy | Plasma renin activity | Ambulatory blood pressure measurement | SYSTEM | plasma renin activity | DESIGN | ANTAGONIST | MYOCARDIAL-INFARCTION | aliskiren | TISSUE | ambulatory blood pressure measurement | SOCIETY | renin-angiotensin-aldosterone system | RISK-FACTOR | combination therapy | PERIPHERAL VASCULAR DISEASE | renin inhibitor | ESSENTIAL-HYPERTENSION | ALDOSTERONE | hypertension | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Biphenyl Compounds - adverse effects | Amides | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Biphenyl Compounds - therapeutic use | Hypertension - blood | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Drug Therapy, Combination | Hypertension - diagnosis | Ramipril - adverse effects | Hydrochlorothiazide - adverse effects | Fumarates - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Renin - blood | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Antihypertensive Agents - blood | Fumarates - blood | Renin - antagonists & inhibitors | Tetrazoles - therapeutic use | Aged | Patient Compliance | Tetrazoles - adverse effects | Blood Pressure Monitoring, Ambulatory | Hydrochlorothiazide - therapeutic use
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2003, Volume 289, Issue 16, pp. 2073 - 2082
Journal Article
American journal of kidney diseases, ISSN 0272-6386, 2008, Volume 52, Issue 3, pp. 486 - 493
Journal Article
Journal Article
Kidney international, ISSN 0085-2538, 06/2008, Volume 73, Issue 11, pp. 1303 - 1309
..., stroke, or cardiovascular death irrespective of their diabetes status.Important therapeutic strategies to slow the decline in kidney function includes... 
albuminuria | diabetes mellitus | benazepril | hypertension | amlodipine | hydrochlorothiazide | Hypertension | Amlodipine | Benazepril | Albuminuria | Hydrochlorothiazide | Diabetes mellitus | RENAL-FUNCTION | RISK | DIABETIC-NEPHROPATHY | BLOOD-PRESSURE | GLOMERULAR-FILTRATION-RATE | MICROALBUMINURIA | DISEASE | UROLOGY & NEPHROLOGY | ESSENTIAL-HYPERTENSION | PROGRESSION | Calcium Channel Blockers - adverse effects | Diabetic Nephropathies - etiology | Benzazepines - adverse effects | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Diabetic Nephropathies - drug therapy | Hypertension - drug therapy | Male | Hypertension - etiology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Blood Pressure - drug effects | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hydrochlorothiazide - adverse effects | Albuminuria - etiology | Double-Blind Method | Amlodipine - adverse effects | Treatment Outcome | Benzazepines - pharmacology | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Benzazepines - therapeutic use | Albuminuria - drug therapy | Diuretics - therapeutic use | Aged | Hydrochlorothiazide - therapeutic use | Diuretics - adverse effects | Index Medicus
Journal Article
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 05/2007, Volume 49, Issue 5, pp. 1047 - 1055
Current guidelines from the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommend first-line treatment... 
Direct renin inhibitor | Obesity | Renin-angiotensin system | Thiazide diuretic | Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 7 | direct renin inhibitor | thiazide diuretic | EFFICACY | Joint National Committee on Prevention, Detection, Evaluation | and Treatment of High Blood Pressure 7 | PERIPHERAL VASCULAR DISEASE | renin angiotensin system | INSULIN SENSITIVITY | obesity | BLOOD-PRESSURE | VALSARTAN | Diastole | Humans | Middle Aged | Biphenyl Compounds - adverse effects | Fumarates - administration & dosage | Hypertension - drug therapy | Male | Systole | Biphenyl Compounds - therapeutic use | Hypertension - blood | Amides - adverse effects | Adult | Female | Blood Pressure - drug effects | Hydrochlorothiazide - adverse effects | Double-Blind Method | Administration, Oral | Fumarates - therapeutic use | Obesity - complications | Amlodipine - adverse effects | Treatment Outcome | Amides - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Renin - blood | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Renin - antagonists & inhibitors | Hypertension - complications | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Amides - administration & dosage | Hydrochlorothiazide - therapeutic use
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 11/2017, Volume 6, Issue 11, p. n/a
...‐blocker combination therapy. What Are the Clinical Implications? Clinicians may use the information to prescribe more appropriate alternative antihypertensive... 
pharmacogenomics | high blood pressure | combination therapy | genomics | β‐blockers | thiazide diuretics | hypertension | Hypertension | Genomics | Thiazide diuretics | High blood pressure | β-blockers | Combination therapy | Pharmacogenomics | ALDOSTERONE SYSTEM EXPRESSION | CARDIAC & CARDIOVASCULAR SYSTEMS | beta-blockers | TRANS-RETINOIC ACID | SR/TRANDOLAPRIL | HEPATIC LIPASE | POLYMORPHISMS | RENIN-ANGIOTENSIN SYSTEM | CHOLESTEROL EFFLUX | CORONARY-ARTERY-DISEASE | GENOME-WIDE ASSOCIATION | Multivariate Analysis | Prospective Studies | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Young Adult | Verapamil - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Pharmacogenomic Variants | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Hypertension - genetics | Hypertension - diagnosis | Odds Ratio | Adrenergic beta-Antagonists - therapeutic use | Hydrochlorothiazide - adverse effects | Genome-Wide Association Study | Pharmacogenetics | Risk Factors | Logistic Models | Treatment Outcome | Retinal Dehydrogenase - genetics | Antihypertensive Agents - therapeutic use | Chi-Square Distribution | Florida | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Drug Resistance - genetics | Atenolol - therapeutic use | Adolescent | Atenolol - adverse effects | Indoles - therapeutic use | Aged | Polymorphism, Single Nucleotide | Georgia | Hydrochlorothiazide - therapeutic use | Drug Combinations
Journal Article